Physician profile
Felicitas Mavunga
NPI 1871957340
$1,157.43
in general payments reported to CMS, 2019-2025
16 companies · $542 in 2025
The $542 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $34.43 · 2023: $250 · 2024: $206 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $201.43 | 2023-2025 | Aristada, Aristada Initio, Lybalvi |
| Jazz Pharmaceuticals INC. | $124.99 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $118.70 | 2024-2025 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $107.23 | 2023-2025 | Caplyta |
| Idorsia Pharmaceuticals US INC | $97.13 | 2023 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $83.04 | 2023-2025 | Trintellix |
| Lundbeck LLC | $81.61 | 2024-2025 | Rexulti |
| Axsome Therapeutics, INC. | $79.89 | 2024-2025 | Auvelity |
| Noven Therapeutics, LLC | $52.87 | 2024-2025 | Xelstrym, Secuado |
| Collegium Pharmaceutical, INC. | $42.33 | 2025 | Jornay Pm |
| Corium, LLC | $40.87 | 2023-2025 | Azstarys |
| Vanda Pharmaceuticals INC. | $37.53 | 2022-2025 | Fanapt |
| Janssen Pharmaceuticals, INC | $36.42 | 2022-2025 | Spravato |
| Supernus Pharmaceuticals, INC. | $20.98 | 2025 | Qelbree |
| Abbvie INC. | $17.52 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $14.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felicitas Mavunga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.